Yanina Balabanova
7PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 26, 2024
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.Gunnar Brobert, Ana Ruigomez, Tania Schink
|Feb 16, 2023
Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries.Luis Alberto García Rodríguez, Ana Ruigómez, Tania Schink
|Feb 01, 2023
Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands.Annemarie Voss, Elisabeth Smits, Karin M A Swart
|Nov 09, 2022
Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United Kingdom.Antonio González-Pérez, Yanina Balabanova, María E Sáez
|May 23, 2022
Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden.Yanina Balabanova, Bahman Farahmand, Hans Garmo
|Nov 22, 2021
Evaluating patient and physician knowledge of risks and safe use of rivaroxaban: a survey across four countries.Laurie Zografos, Dan Wolin, Elizabeth Andrews
Pageof 2
Frequent Collaborators
5 joint publications
Gunnar Brobert
5 joint publications
Kiliana Suzart-Woischnik
4 joint publications
Luis Alberto García-Rodríguez
4 joint publications
Tania Schink
4 joint publications
Ron M C Herings
3 joint publications
Elisabeth Smits
3 joint publications
Annemarie Voss
2 joint publications
Leif Friberg
2 joint publications
Ana Ruigomez
2 joint publications
Montse Soriano-Gabarró
